Literature DB >> 16838767

Piperacillin-tazobactam-induced drug hypersensitivity syndrome.

Simone Fahim1, Vikas Jain, Gary Victor, Tadeusz Pierscianowski.   

Abstract

The drug hypersensitivity syndrome (DHS) is a rare but serious and potentially life-threatening reaction to common drugs in predisposed individuals. The syndrome is a triad of fever, skin eruption, and internal organ involvement. Prompt identification and discontinuation of the offending drug with symptomatic treatment of toxic effects is the mainstay of therapy for DHS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16838767

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  5 in total

1.  Drug rash with eosinophilia and systemic symptoms (DRESS) probably induced by cefotaxime: a report of two cases.

Authors:  Karim Aouam; Amel Chaabane; Adnen Toumi; Nadia Ben Fredj; Foued Ben Romdhane; Naceur A Boughattas; Mohamed Chakroun
Journal:  Clin Med Res       Date:  2011-08-04

2.  A case of piperacillin-induced occupational anaphylaxis: detection of serum IgE to piperacillin-HSA conjugate.

Authors:  Jeong-Eun Kim; Seung-Hyun Kim; Joo-Hee Kim; Joon-Woo Bahn; Hyun Jung Jin; Young-Min Ye; Hae-Sim Park
Journal:  J Korean Med Sci       Date:  2011-04-21       Impact factor: 2.153

3.  DRESS Syndrome in the ICU: When a Patient Is Treated with Multiple Drugs.

Authors:  Florent Moriceau; Johanne Prothet; Benjamin J Blaise; Benoit Ben Said; Mathieu Page; Charles-Eric Ber; Jullien Crozon; Thomas Rimmelé
Journal:  Case Rep Crit Care       Date:  2016-01-24

4.  Piperacillin/Tazobactam-Associated Hypersensitivity Syndrome with Overlapping Features of Acute Generalized Exanthematous Pustulosis and Drug-Related Rash with Eosinophilia and Systemic Symptoms Syndrome.

Authors:  Tae In Kim; Ki Heon Jeong; Min Kyung Shin; Nack In Kim
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444

Review 5.  Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review.

Authors:  Shiva Sharifzadeh; Amir Hooshang Mohammadpour; Ashraf Tavanaee; Sepideh Elyasi
Journal:  Eur J Clin Pharmacol       Date:  2020-10-06       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.